Sleep apnea and the subsequent risk of parkinson’s disease: A 3-year nationwide population-based study

Ping Song Chou, Chiou Lian Lai, Yii Her Chou, Wei Pin Chang

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose: Sleep apnea (SA)-induced chronic intermittent hypoxia increases oxidative stress and inflammation, which may contribute to the pathophysiology of Parkinson’s disease (PD). This study evaluated the risk of PD following SA diagnosis. Patients and methods: This was a 3-year nationwide population-based matched cohort study using claims data from the National Health Insurance Research Database (NHIRD), Taiwan. We analyzed 1,944 patients diagnosed as having SA between 1997 and 2005 and a matched cohort of 9,720 non-SA patients from the NHIRD. Patients with a history of PD were excluded. Each patient was followed up for 3 years to evaluate subsequent PD development. Results: Of the 11,664 patients, 17 (0.9%) and 38 (0.4%) from the SA and matched non-SA cohorts, respectively, were subsequently diagnosed as having PD during follow-up. After adjustments for potential confounders, the SA cohort had a 1.85-fold higher risk of PD than the non-SA cohort (95% confidence interval [CI] =1.02–3.35; P=0.042). After age and sex stratification, PD development was independently associated with SA only in men (adjusted hazard ratio [HR], 2.26; 95% CI =1.11–4.63; P<0.05) and in patients aged ≥60 years (adjusted HR, 1.93; 95% CI =1.01–3.71; P<0.05). Conclusion: Our study suggests that patients with SA are at an increased longitudinal risk of PD. Furthermore, age and male sex are independently associated with the risk of PD.

Original languageEnglish
Pages (from-to)959-965
Number of pages7
JournalNeuropsychiatric Disease and Treatment
Volume13
DOIs
Publication statusPublished - Mar 30 2017

Fingerprint

Sleep Apnea Syndromes
Parkinson Disease
Population
Apnea
National Health Programs
Confidence Intervals
Databases
Parkinson disease 3
Taiwan
Research
Oxidative Stress
Cohort Studies
Inflammation

Keywords

  • Cohort study
  • Intermittent hypoxia
  • National Health Insurance Research Database
  • Population-based study

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Sleep apnea and the subsequent risk of parkinson’s disease : A 3-year nationwide population-based study. / Chou, Ping Song; Lai, Chiou Lian; Chou, Yii Her; Chang, Wei Pin.

In: Neuropsychiatric Disease and Treatment, Vol. 13, 30.03.2017, p. 959-965.

Research output: Contribution to journalArticle

@article{d3456aa141214b10855328faa26ee65f,
title = "Sleep apnea and the subsequent risk of parkinson’s disease: A 3-year nationwide population-based study",
abstract = "Purpose: Sleep apnea (SA)-induced chronic intermittent hypoxia increases oxidative stress and inflammation, which may contribute to the pathophysiology of Parkinson’s disease (PD). This study evaluated the risk of PD following SA diagnosis. Patients and methods: This was a 3-year nationwide population-based matched cohort study using claims data from the National Health Insurance Research Database (NHIRD), Taiwan. We analyzed 1,944 patients diagnosed as having SA between 1997 and 2005 and a matched cohort of 9,720 non-SA patients from the NHIRD. Patients with a history of PD were excluded. Each patient was followed up for 3 years to evaluate subsequent PD development. Results: Of the 11,664 patients, 17 (0.9{\%}) and 38 (0.4{\%}) from the SA and matched non-SA cohorts, respectively, were subsequently diagnosed as having PD during follow-up. After adjustments for potential confounders, the SA cohort had a 1.85-fold higher risk of PD than the non-SA cohort (95{\%} confidence interval [CI] =1.02–3.35; P=0.042). After age and sex stratification, PD development was independently associated with SA only in men (adjusted hazard ratio [HR], 2.26; 95{\%} CI =1.11–4.63; P<0.05) and in patients aged ≥60 years (adjusted HR, 1.93; 95{\%} CI =1.01–3.71; P<0.05). Conclusion: Our study suggests that patients with SA are at an increased longitudinal risk of PD. Furthermore, age and male sex are independently associated with the risk of PD.",
keywords = "Cohort study, Intermittent hypoxia, National Health Insurance Research Database, Population-based study",
author = "Chou, {Ping Song} and Lai, {Chiou Lian} and Chou, {Yii Her} and Chang, {Wei Pin}",
year = "2017",
month = "3",
day = "30",
doi = "10.2147/NDT.S134311",
language = "English",
volume = "13",
pages = "959--965",
journal = "Neuropsychiatric Disease and Treatment",
issn = "1176-6328",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Sleep apnea and the subsequent risk of parkinson’s disease

T2 - A 3-year nationwide population-based study

AU - Chou, Ping Song

AU - Lai, Chiou Lian

AU - Chou, Yii Her

AU - Chang, Wei Pin

PY - 2017/3/30

Y1 - 2017/3/30

N2 - Purpose: Sleep apnea (SA)-induced chronic intermittent hypoxia increases oxidative stress and inflammation, which may contribute to the pathophysiology of Parkinson’s disease (PD). This study evaluated the risk of PD following SA diagnosis. Patients and methods: This was a 3-year nationwide population-based matched cohort study using claims data from the National Health Insurance Research Database (NHIRD), Taiwan. We analyzed 1,944 patients diagnosed as having SA between 1997 and 2005 and a matched cohort of 9,720 non-SA patients from the NHIRD. Patients with a history of PD were excluded. Each patient was followed up for 3 years to evaluate subsequent PD development. Results: Of the 11,664 patients, 17 (0.9%) and 38 (0.4%) from the SA and matched non-SA cohorts, respectively, were subsequently diagnosed as having PD during follow-up. After adjustments for potential confounders, the SA cohort had a 1.85-fold higher risk of PD than the non-SA cohort (95% confidence interval [CI] =1.02–3.35; P=0.042). After age and sex stratification, PD development was independently associated with SA only in men (adjusted hazard ratio [HR], 2.26; 95% CI =1.11–4.63; P<0.05) and in patients aged ≥60 years (adjusted HR, 1.93; 95% CI =1.01–3.71; P<0.05). Conclusion: Our study suggests that patients with SA are at an increased longitudinal risk of PD. Furthermore, age and male sex are independently associated with the risk of PD.

AB - Purpose: Sleep apnea (SA)-induced chronic intermittent hypoxia increases oxidative stress and inflammation, which may contribute to the pathophysiology of Parkinson’s disease (PD). This study evaluated the risk of PD following SA diagnosis. Patients and methods: This was a 3-year nationwide population-based matched cohort study using claims data from the National Health Insurance Research Database (NHIRD), Taiwan. We analyzed 1,944 patients diagnosed as having SA between 1997 and 2005 and a matched cohort of 9,720 non-SA patients from the NHIRD. Patients with a history of PD were excluded. Each patient was followed up for 3 years to evaluate subsequent PD development. Results: Of the 11,664 patients, 17 (0.9%) and 38 (0.4%) from the SA and matched non-SA cohorts, respectively, were subsequently diagnosed as having PD during follow-up. After adjustments for potential confounders, the SA cohort had a 1.85-fold higher risk of PD than the non-SA cohort (95% confidence interval [CI] =1.02–3.35; P=0.042). After age and sex stratification, PD development was independently associated with SA only in men (adjusted hazard ratio [HR], 2.26; 95% CI =1.11–4.63; P<0.05) and in patients aged ≥60 years (adjusted HR, 1.93; 95% CI =1.01–3.71; P<0.05). Conclusion: Our study suggests that patients with SA are at an increased longitudinal risk of PD. Furthermore, age and male sex are independently associated with the risk of PD.

KW - Cohort study

KW - Intermittent hypoxia

KW - National Health Insurance Research Database

KW - Population-based study

UR - http://www.scopus.com/inward/record.url?scp=85018521843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018521843&partnerID=8YFLogxK

U2 - 10.2147/NDT.S134311

DO - 10.2147/NDT.S134311

M3 - Article

AN - SCOPUS:85018521843

VL - 13

SP - 959

EP - 965

JO - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

SN - 1176-6328

ER -